Aplastic Anemia - 30 Studies Found

Completed : Gene Therapy for the Treatment of Fanconi's Anemia Type C
:
  • Fanconi's Anemia
  • Pancytopenia

: 1999-11-03
: Drug: Transduced CD34+ Cells
Completed : Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
: Fanconi's Anemia
: 2000-08-03
: Drug: amifostine
Terminated : Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia
:
  • Fanconi Anemia
  • Severe Aplastic Anemia

: 2007-12-26
:
  • Biological: CAMPATH-1H Given i
Completed : Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia
: Fanconi's Anemia
: 2000-06-02
:
  • Drug: cyclophosphamide
  • Procedure: Allogene
Completed : Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia
: Fanconi's Anemia
: 2000-06-02
:
  • Drug: filgrastim
  • Genetic: Autologous stem

Completed : Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
:
  • Neutropenic Enterocolitis
  • Myeloablative Chemotherapy Induced Bone Marr
    : 2014-05-21
    :
    • Procedure: Peripheral blood stem cell mobilisation and collection
Completed : A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
: Severe Aplastic Anemia
: 2025-08-03
: cyclosporine
Completed : Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy
: Aplastic Anemia
: 2025-08-03
: if trepanobiopsy was performed during the diagnosis, then comparison with MRI Bone marrow cellularity by mDixon-quant
COMPLETED : Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
: Aplastic Anemia
: 2025-08-03
: Daratumumab is a monoclonal globulin targeting the CD38 molecule of immune cells, which can eliminate antigen-presenting cells such as dendritic cells
COMPLETED : Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia
: Non Severe Aplastic Anemia
: 2025-08-03
: Hetrombopag is a TPO receptor agonist approved in China in 2021 for idiopathic thrombocytopenic purpura (ITP) and second-line severe aplastic anemi
<<< Previous